Survival status and its predictors among undernourished children on antiretroviral therapy in Bahir Dar city, Northwest Ethiopia, 2010 – 2020, a multicenter retrospective cohort study
Open Access
- 30 April 2024
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 1-15
Abstract
Background: In environments with limited resources, undernutrition is a serious public health risk. Its dual relationship to human immunodeficiency virus infection (HIV) leads to crises in a child's physical, emotional, social, and economic spheres of life. Nevertheless, little research has been done on the survival rate and risk factors that lead to poor survival outcomes in undernourished children receiving antiretroviral therapy. This study sought to evaluate survival status and its predictors among undernourished children on antiretroviral therapy (ART) in public health facilities, Bahir Dar city, September 1, 2010 – December 31, 2020.Methods: An institution-based retrospective cohort study design was used among 414 study participants from September 1, 2010 – December 31, 2020. A simple random sampling method was applied to select study participants. All collected data were entered into epi data version 4.6 and exported to STATA version 14.0 for analysis. Each independent predictor variable with ap-value < 0.05 in the multivariable Cox proportional hazard regression was considered statistically significant.Results: The overall incidence of mortality was 11.6 deaths per 1000 child year observation (95%CI: 7.7- 17.5). Baseline weight for age < -3 Z score (adjusted hazard ratio (AHR) = 4.9, 95% CI: 1.30–18.98), height for age < -3 Z score (AHR = 4.34, 95%CI 1.13–16.6), cotrimoxazole prophylaxis given (AHR = 0.27, 95%CI 0.08–0.87), hemoglobin level < 10 g/dl (AHR = 3.7, 95%CI 1.1–12.7), CD4 cells < threshold (AHR = 4.86, 95%CI 1.9–12.7), and WHO clinical disease stage III and IV (AHR = 8.1, 95%CI 1.97–33) were found independent predictors of mortality.Conclusion and recommendation: The incidence of mortality was determined in the study to be 11.6 per 1000 child years. Mortality was predicted by severe stunting, severe underweight, a low hemoglobin level, a low CD4 count, and WHO clinical stages III and IV. But the risk of death is reduced by starting cotrimoxazole preventative therapy early. The risk factors that result in a low survival status should be the primary focus of all concerned bodies, and early cotrimoxazole preventive treatment initiation is strongly recommended.Keywords
This publication has 46 references indexed in Scilit:
- Measuring malnutrition in all its forms: An update of the net state of nutrition index to track the global burden of malnutrition at country levelGlobal Food Security, 2020
- The global epidemiology of adolescents living with HIVCurrent Opinion in HIV and AIDS, 2018
- Predictors of Virologic Failure on First-line Antiretroviral Therapy Among Children in a Referral Pediatric Center in CameroonThe Pediatric Infectious Disease Journal, 2017
- Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus–Infected YouthJAMA Pediatrics, 2017
- Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapyMedecine Et Maladies Infectieuses, 2017
- Growth of HIV-Infected Children in the Early Stage of Antiretroviral Treatment: A Retrospective Cohort Study in ChinaAIDS Patient Care and STDs, 2016
- Predictors of Mortality and Mortality Rate in a Cohort of Children Living with HIV from IndiaIndian Journal of Pediatrics, 2016
- Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV‐infected patients on antiretroviral therapy in sub‐Saharan AfricaTropical Medicine & International Health, 2015
- Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income CountriesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- Long‐Term Survival of HIV‐Infected Children Receiving Antiretroviral Therapy in Thailand: A 5‐Year Observational Cohort StudyClinical Infectious Diseases, 2010